Statement by FDA Commissioner Scott Gottlieb, M.D., and Biologics Center Director Peter Marks, M.D., Ph.D. on FDA’s continued efforts to stop stem cell clinics and manufacturers from marketing unapproved products that put patients at risk - FDA Press Releases

FDA statement on stem cell enforcement actions and agency activities to facilitate legitimate product development

from FDA Press Releases RSS Feed https://ift.tt/2qMoxjz
via IFTTT